
Who’s at risk for fatty liver disease, from the Harvard Health Letter
January 2011
Up to 20% of American adults have some degree of fatty liver disease, a condition that used to occur almost exclusively in people who drink too much alcohol. The increase can be blamed on the twin epidemics of obesity and diabetes, reports the January 2011 issue of the Harvard Health Letter.
One leading theory is that the condition starts when muscle, fat, and liver cells stop responding normally to insulin. This so-called insulin resistance is a hallmark of obesity and diabetes. Insulin resistance also increases the amount of fat molecules circulating in the blood. The accumulation of these molecules inside liver cells can lead to liver inflammation and damage. This is called nonalcoholic steatohepatitis (NASH).
NASH is often a relatively stable condition with few if any symptoms. But it can also lead to serious damage to the liver and its function — a condition called cirrhosis.
A liver biopsy is the only way to definitively diagnose fatty liver disease or NASH. In most cases, weight loss is the only recommended treatment. As people lose weight, the fatty liver becomes less fatty.
The Harvard Health Letter notes that there are two bright spots about fatty livers. First, most cases don’t result in serious liver disease. Second, the treatment is to lose weight —and that will benefit many other parts of the body besides the liver.
Read the full-length article: "When the liver gets fatty"
Also in this issue of the Harvard Health Letter
- Finding lung cancer early
- Let's go nuts
- When the liver gets fatty
- On the brain: Maybe more than one way to beat cognitive decline
- On the brain: The brainy omega-3 fails an Alzheimer's test
- In Brief: Good news about new macular degeneration drugs
- In Brief: Old noses have more room inside
- In Brief: Sleep helps with fat reduction
- Ask the doctor: Should I be worried about my blood pressure medication causing cancer?
- Ask the doctor: Should I stop taking Avandia?
- Transcript of National Cancer Institute press briefing about the trial using CT scans to screen for lung cancer
More Harvard Health News »
About Harvard Health Publications
Harvard Health Publications publishes four monthly newsletters--Harvard Health Letter, Harvard Women's Health Watch, Harvard Men's Health Watch, and Harvard Heart Letter--as well as more than 50 special health reports and books drawing on the expertise of the 8,000 faculty physicians at Harvard Medical School and its world-famous affiliated hospitals.
